Across-the-board price increases may not maximize the ROI; whereas, significant net revenue yields can be obtained through strategic pricing. iMedX's ability to compare line item pricing to like market entities often results in meaningful increases in profit margin, while ensuring fair prices.
SCOPE: iMedX clients define the market compare group, set limits on price changes and control the pricing decisions. As an independent consulting group, iMedX can offer these services to providers while maintaining the confidentiality key to your pricing decisions. iMedX can also link your pricing decisions to charity and self-pay policies which are increasingly important.
We are always here to help.